These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6348343)

  • 21. [Clinical evaluation of cefminox in pediatric field].
    Ichihara K; Ueda S; Nakashima T; Miyachi Y; Yafuso M; Kuno K
    Jpn J Antibiot; 1985 Mar; 38(3):693-704. PubMed ID: 3897603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory and clinical studies on cefminox in the pediatric field].
    Hosoda T; Ichioka T; Ito M; Sekiguchi T; Miyao M
    Jpn J Antibiot; 1985 Mar; 38(3):766-72. PubMed ID: 3897607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical studies on cefminox in pediatric field].
    Sato T; Tasaki H; Ueda K; Kuroiwa T
    Jpn J Antibiot; 1985 Mar; 38(3):784-90. PubMed ID: 3897609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A clinical study on cefditoren pivoxil granules in the pediatric field].
    Mori A; Meguro H; Terashima I; Fujii R
    Jpn J Antibiot; 1993 Jul; 46(7):577-88. PubMed ID: 8371493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies on cefminox in the field of pediatrics].
    Haruta T; Kuroki S; Ohkura K; Kobayashi Y
    Jpn J Antibiot; 1985 Mar; 38(3):737-42. PubMed ID: 3897606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fundamental and clinical studies on cefminox in the field of pediatrics].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1985 Mar; 38(3):705-19. PubMed ID: 3897604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical efficacy of T-1982 (cefbuperazone) for infections of children].
    Kurashige T; Kitamura I; Ogura H; Wakiguchi H; Morita H; Kuramitsu M; Kuroiwa Y; Tone Y; Mino M
    Jpn J Antibiot; 1983 Apr; 36(4):877-80. PubMed ID: 6876377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A clinical observation of cefuroxime in pediatric field (author's transl)].
    Ohnuma K; Asuka N; Aoyama R; Nagata K
    Jpn J Antibiot; 1979 Nov; 32(11):1117-21. PubMed ID: 41955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation of a new oral cephalosporin preparation, cephradine dry syrup, in pediatrics (author's transl)].
    Fujii R; Yoshioka H; Nakamura T; Nakazawa S; Hori M
    Jpn J Antibiot; 1975 Apr; 28(2):125-31. PubMed ID: 239262
    [No Abstract]   [Full Text] [Related]  

  • 30. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S
    Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Laboratory and clinical studies on 6059-S in children (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Osuga T; Inokuma K
    Jpn J Antibiot; 1981 May; 34(5):782-99. PubMed ID: 6457176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of effectiveness of cefmetazole in bone and joint infections in the orthopedic field].
    Yamane S; Tako H; Yoda Y
    Jpn J Antibiot; 1982 Aug; 35(8):1945-50. PubMed ID: 6759694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of moxalactam for gram-negative and Haemophilus influenzae meningitis: an appraisal.
    Dillon HC
    J Pediatr; 1981 Dec; 99(6):907-8. PubMed ID: 6458672
    [No Abstract]   [Full Text] [Related]  

  • 34. [Susceptibility of bacteria isolated from patients with lower respiratory tract infections to antibiotics (1987)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Kondou T; Saitou A; Matsumiya H; Ueda K; Terai T
    Jpn J Antibiot; 1990 Jan; 43(1):147-80. PubMed ID: 2112206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of cefminox, a new cephamycin antibiotic, in the pediatric infections].
    Ohnari S; Meguro H; Nonaka C; Tajima T; Takahashi S; Fujii R
    Jpn J Antibiot; 1985 Mar; 38(3):671-8. PubMed ID: 3928938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sensitivity of frequent-occurring isolates in outpatients to routinely-used antibiotics (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1979 Jun; 32(6):668-74. PubMed ID: 381708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
    Bégué P; Safran C; Fleurette J; Brun Y; Floret D; Monnet P
    Sem Hop; 1983 Jun; 59(26):1972-6. PubMed ID: 6310789
    [No Abstract]   [Full Text] [Related]  

  • 38. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic resistance of pathogenic bacteria related to respiratory infections in children from Shanghai].
    Che DT; Lu M; Zhang H; Li WH; Lu Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):338-40. PubMed ID: 16923372
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug sensitivity of bacteria isolated from clinical samples (author's transl)].
    Sawatari K; Mochida C; Iori F; Hayashi A; Nasu M
    Jpn J Antibiot; 1980 Jan; 33(1):87-96. PubMed ID: 6990050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.